Fairfield, Bush & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13
| Closed | -$1K | – | 336 |
|
|
2022
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 431 |
|
|
2020
Q2 | – | Sell |
-813
| Closed | -$218K | – | 147 |
|
|
2020
Q1 | $218K | Sell |
813
-27
| -3% | -$7.24K | 0.09% | 116 |
|
|
2019
Q4 | $272K | Sell |
840
-33
| -4% | -$10.7K | 0.1% | 124 |
|
|
2019
Q3 | $239K | Sell |
873
-67
| -7% | -$18.3K | 0.08% | 134 |
|
|
2019
Q2 | $502K | Hold |
940
| – | – | 0.17% | 95 |
|
|
2019
Q1 | $474K | Buy |
940
+140
| +18% | +$70.6K | 0.16% | 99 |
|
|
2018
Q4 | $394K | Hold |
800
| – | – | 0.14% | 106 |
|
|
2018
Q3 | $732K | Hold |
800
| – | – | 0.21% | 94 |
|
|
2018
Q2 | $586K | Hold |
800
| – | – | 0.17% | 100 |
|
|
2018
Q1 | $1.28M | Hold |
800
| – | – | 0.37% | 56 |
|
|
2017
Q4 | $717K | Hold |
800
| – | – | 0.2% | 83 |
|
|
2017
Q3 | $288K | Buy |
+800
| New | +$288K | 0.09% | 125 |
|